1 hour ago
Q32 Bio (QTTB) Shares Soar 60% After Positive Alopecia Treatment Trial Results
Q32 Bio (QTTB) stock soared 60% after bempikibart achieved primary endpoint in Phase 2a alopecia trial, showing 35.3% SALT score reduction with clean safety.
The post Q32 Bio (QTTB) Shares Soar 60% After Positive Alopecia Treatment Trial Results appeared first on Blockonomi.
Source: Blockonomi →Related News
- 58 minutes ago
UnitedHealth (UNH) Q2 Earnings Preview: Wall Street Predictions for July 16 Repo...
- 1 hour ago
Goldman Sachs (GS) Q2 2026 Earnings Preview: Wall Street Eyes Strong Growth Tues...
- 1 hour ago
Mint Inc (MIMI) Stock Soars 39% Following Singapore Robotics Acquisition Announc...
- 1 hour ago
Volkswagen Eyes Massive 100,000 Job Cuts Amid Mounting Cost Pressures
- 1 hour ago
Western Digital (WDC) Stock Plunges 7% Amid SK Hynix Collapse and Memory Sector...